| scholarly article | Q13442814 |
| P50 | author | Nicholas Talley | Q7026286 |
| P2093 | author name string | Eric L Matteson | |
| Cynthia S Crowson | |||
| Elena Myasoedova | |||
| P2860 | cites work | Diverticulosis--a primary cause of life-threatening complications in rheumatoid arthritis | Q72295501 |
| Sigmoid diverticular abscess perforation in 2 patients with rheumatoid arthritis treated with high dose corticosteroids. A cautionary tale | Q74385184 | ||
| A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology | Q77573373 | ||
| Extra-articular rheumatoid arthritis: prevalence and mortality | Q78169221 | ||
| Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years | Q78794833 | ||
| Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis | Q80552769 | ||
| Abdominal surgical interventions: local and systemic consequences for the immune system--a prospective study on elective gastrointestinal surgery | Q81785933 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis | Q28165567 | ||
| A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use | Q28186337 | ||
| The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis | Q28211833 | ||
| A review of the gastrointestinal safety data--a gastroenterologist's perspective | Q33560647 | ||
| Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy. | Q33668300 | ||
| The mortality of rheumatoid arthritis | Q34338843 | ||
| Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases | Q34359522 | ||
| History of the Rochester Epidemiology Project | Q34374377 | ||
| The incidence of gastrointestinal perforations among rheumatoid arthritis patients | Q34543316 | ||
| Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. | Q34609572 | ||
| Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. | Q34621619 | ||
| IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial | Q34795777 | ||
| Co-morbidity in rheumatoid arthritis | Q35198206 | ||
| Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions | Q35554114 | ||
| Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib | Q35875744 | ||
| Autoimmune disorders: gastrointestinal manifestations and endoscopic findings | Q36424709 | ||
| Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs | Q36570803 | ||
| Comorbidities in rheumatoid arthritis | Q36942648 | ||
| The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases | Q37027093 | ||
| Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability | Q37165495 | ||
| Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis | Q37344503 | ||
| Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review. | Q37915351 | ||
| Adherence to healthy lifestyle habits in US adults, 1988-2006. | Q39974747 | ||
| Comorbidity in arthritis. | Q40790498 | ||
| NSAID-associated upper gastrointestinal damage in patients with rheumatoid arthritis. | Q40956025 | ||
| Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). | Q41998132 | ||
| Smoking, use of moist snuff, and risk of chronic inflammatory diseases | Q43142643 | ||
| Causes of death in patients with rheumatoid arthritis autopsied during a 40-year period | Q43471107 | ||
| Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. | Q44295966 | ||
| Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. | Q45940021 | ||
| The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients | Q64112284 | ||
| Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases | Q67592894 | ||
| Trends in hospitalizations for gastrointestinal bleeding among patients with rheumatoid arthritis in Rochester, Minnesota, 1950-1991 | Q71514119 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1355-1362 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study | |
| P478 | volume | 39 |
| Q38996808 | A Case of Diverticular Perforation in a Young Patient with Rheumatoid Arthritis on Methotrexate |
| Q37331767 | Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease |
| Q38821076 | Breath Methane Levels Are Increased Among Patients with Diverticulosis |
| Q39744551 | Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments |
| Q35101759 | Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota |
| Q31137082 | Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources |
| Q36754750 | Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20-30 years |
| Q34610490 | Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based Study |
| Q33731689 | Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs |
| Q49653275 | Sex differences in risk factors of uncomplicated colonic diverticulosis in a metropolitan area from Northern China |
| Q64235572 | The Association between Absence of Abdominal Pain and Mortality in Lower Intestinal Perforation in Patients with Autoimmune Rheumatic Diseases |
Search more.